Cargando…
A Pragmatic Clinical Trial to Compare the Real-World Effectiveness of V-Go versus Standard Delivery of Insulin in Patients with Advanced Type 2 Diabetes
Background: Many patients with type 2 diabetes mellitus (T2DM) do not have adequate glycemic control, leading to poor patient outcomes and high healthcare costs. Objective: This prospective pragmatic clinical trial evaluated V-Go, a wearable insulin delivery device, compared with standard treatment...
Autores principales: | Cziraky, Mark J., Abbott, Scott, Nguyen, Matt, Larholt, Kay, Apgar, Elizabeth, Wasser, Thomas, Strange, Poul, Shi, Leon, Harrison, H. Courtenay, Everitt, Beverly, Nowak, Lynn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Columbia Data Analytics, LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299448/ https://www.ncbi.nlm.nih.gov/pubmed/32685581 http://dx.doi.org/10.36469/9731 |
Ejemplares similares
-
Impact of a Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses
por: Schneider, John E., et al.
Publicado: (2018) -
Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey
por: Satman, Ilhan, et al.
Publicado: (2013) -
Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation Model
por: Wahlqvist, Peter, et al.
Publicado: (2018) -
A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study
por: Gordon, J, et al.
Publicado: (2010) -
Cost Savings and Reduced Health Care Utilization Associated with Participation in a Digital Diabetes Prevention Program in an Adult Workforce Population
por: Sweet, Cynthia Castro, et al.
Publicado: (2020)